Company page

Skinbiotherapeutics Plc

Skinbiotherapeutics Plc, trading under the ticker SBTX, is a public company based in the UK with a market capitalization of approximately £33.76 million. The company focuses on developing skin health products through the application of its proprietary technology. Skinbiotherapeutics aims to leverage advancements in microbiome science to create innovative solutions for skin conditions.

profileSBTXAI content: aiUpdated May 23, 2026/company/skinbiotherapeutics-plc
Skinbiotherapeutics Plc logo
Ticker
SBTX
Market cap
$33.8M
Sector
Health Technology
Industry
Pharmaceuticals: Other